Abstract:OBJECTIVE: The purpose of this review is to clarify the potential roles of forkhead box transcription factor M1 (FoxM1) in the occurrence and progression of breast cancer, as well as the predictive value of FoxM1 as a prognostic biomarker and potential therapeutic target for breast cancer.BACKGROUND: Breast cancer, well-known as a molecularly heterogeneous cancer, is still one of the most frequently diagnosed malignant tumors among females worldwide. Tumor recurrence and metastasis are the central causes of high mortality in breast cancer patients. Many factors contribute to the occurrence and progression of breast cancer, including FoxM1. FoxM1, widely regarded as a classic proliferation-related transcription factor, plays pivotal roles in the occurrence, proliferation, invasion, migration, drug resistance, and epithelial-mesenchymal transition (EMT) processes of multiple human tumors including breast cancer.METHODS: The PubMed database was searched for articles published in English from February 2008 to May 2021 using related keywords such as "forkhead box transcription factor M1", "human breast cancer", "FoxM1", and "human tumor". About 90 research papers and reports written in English were identified, most of which were published after 2015. These papers mainly concentrated on the functions of FoxM1 in the occurrence, development, drug resistance, and treatment of human breast cancer.CONCLUSIONS: Considering that the abnormal expression of FoxM1 plays a significant role in the proliferation, invasion, metastasis, and chemotherapy drug resistance of breast cancer, and its overexpression is closely correlated with the unfavorable clinicopathological characteristics of breast tumor patients, it is considerably important to comprehend the regulatory mechanism of FoxM1 in breast cancer. This will provide strong evidence for FoxM1 as a potential biomarker for the targeted treatment and prognostic evaluation of breast cancer patients.

Research Advances of FOXM1 in Non-small Cell Lung Carcinomas

FoxM1: a Novel Tumor Biomarker of Lung Cancer.

Research Progress in the Relationship Between FOXM1 and Neoplasm Metabolism

FOXN Transcription Factors: Regulation and Significant Role in Cancer

Role of Transcription Factor FOXA1 in Non‑small Cell Lung Cancer.

Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.

Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest

Clinical Significance and Functional Roles of Foxm1 in Non-Small Cell Lung Cancer

FOXM1 promotes the progression of non-small cell lung cancer by inhibiting miR-509-5p expression via binding to the miR-509-5p promoter region

Foxm1 Is Associated With Poor Prognosis Of Non-Small Cell Lung Cancer Patients Through Promoting Tumor Metastasis

FoxM1 as a novel therapeutic target for cancer drug therapy.

Research advancement of FoxM1 in digestive system tumors

[Role of Inhibition of Transcription Factor Forkhead Box M1 Expression by RNA Interference in the Proliferation and Invasiveness of Non-Small Cell Lung Cancer Cells].

Foxm1 Mediated Resistance to Gefitinib in Non-Small-Cell Lung Cancer Cells

SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1

Correlation Between Expression of Forkhead Box M1 (FOXM1) and Clinicopathological Features and Prognosis in Patients with Non-Small Cell Lung Cancer (NSCLC)

The Expression and Survival Significance of FOXD1 in Lung Squamous Cell Carcinoma: A Meta-Analysis, Immunohistochemistry Validation, and Bioinformatics Analysis

miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.

A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics

FOXM1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Upregulating SNAIL

FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma